New Jersey Attorney General Jeffrey S. Chiesa has announced a reorganization of the Division of Consumer Affairs Enforcement Bureau, in a bid to better tackle prescription drug diversion and abuse. The reorganization sees the bureau made up of: 1) a Drug Diversion Section, which investigates the distribution and diversion of prescription drugs; prescribing and dispensing; prescription fraud; and the enforcement of bans; 2)Pharmacy Inspection Section; and 3)Quality of Healthcare Section which conducts investigations from the Boards of Medical Examiners and Nursing, including impairment and practitioner-use, as well as health insurance fraud. The bureau also includes General Investigations and General Inspections sections.
More.
